Engineered endocrine objects tolerate hypoxia in macroencapsulation devices and enable subcutaneous engraftment in diabetic mice
Islet encapsulation has been pursued for decades as a potential immunosuppression-free transplantation strategy to treat type 1 diabetes (T1D). The encapsu